FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and aims at managing or preventing post-chemotherapeutic pain or pains induced by an anti-cancer agent. What is declared is the use of at least one type A botulinum neurotoxin for preparing a medicine for managing or preventing post-chemotherapeutic pain or pains. What is also declared is a method of managing or preventing post-chemotherapeutic pain or pains by local introduction of said medicine to achieve a generalised effect.
EFFECT: use of the declared group of inventions provides a high therapeutic effect.
2 ex, 3 dwg, 32 cl
| Title | Year | Author | Number |
|---|---|---|---|
| SIMULTANEOUS, SEPARATE OR SEPARATED IN TIME THERAPEUTIC APPLICATION OF, AT LEAST, ONE BOTULIC NEUROTOXIN AND, AT LEAST, ONE OPIATE DERIVATIVE | 2007 |
|
RU2434637C2 |
| NEW COMPOSITION FOR TREATING SIDE EFFECTS OF ANTI-CANCER THERAPY | 2008 |
|
RU2485956C2 |
| SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER | 2019 |
|
RU2791640C2 |
| USING COMPOUNDS BINDING TO SIGMA RECEPTOR LIGANDS FOR TREATING NEUROPATHIC PAIN PROGRESSION CAUSED BY CHEMOTHERAPY | 2009 |
|
RU2537226C2 |
| LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
| USE OF BUTYL PHTHALIDE AND ITS DERIVATIVES | 2021 |
|
RU2812533C1 |
| SIGMA-RECEPTOR LIGANDS FOR PREVENTING OR TREATING PAIN CAUSED BY CHEMOTHERAPY | 2010 |
|
RU2543382C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING PAIN SYNDROME IN FOOT, COMPRISING BOTULINUM TOXIN AND HYALURONIC ACID, AND METHOD OF TREATING PAIN SYNDROME IN FOOT WITH USE THEREOF | 2018 |
|
RU2734159C1 |
| METHODS FOR USING A PHENOXYPROPYLAMINE COMPOUND FOR THE TREATMENT OF PAIN | 2019 |
|
RU2797615C2 |
| APPLICATION OF DIHYDROMIDASOPIRAZINE FOR PAIN PREVENTION OR MANAGEMENT | 2005 |
|
RU2388474C2 |
